%0 Journal Article
%T Clinical and molecular analysis of nine fetal cases with clinically significant variants causing nemaline myopathy.
%A Yu QX
%A Zhen L
%A Lin XM
%A Wen YJ
%A Li DZ
%J Eur J Obstet Gynecol Reprod Biol
%V 292
%N 0
%D 2024 Jan 7
%M 38071834
%F 2.831
%R 10.1016/j.ejogrb.2023.12.005
%X <B>OBJECTIVE: </B>To present the prenatal features and postnatal outcomes of pregnancies with fetal nemaline myopathy (NM).<BR><B>METHODS: </B>This was a retrospective study of nine cases with NM diagnosed by prenatal or postnatal clinical features and confirmed by genetic testing. Clinical and laboratory data were collected and reviewed for these cases, including maternal demographics, prenatal sonographic findings, exome sequencing (ES) results, and pregnancy outcomes.<BR><B>RESULTS: </B>All of the nine cases were detected to have NM-causing variants, involving NEB gene in 2 cases, ACTA1 in 3 cases, KLHL40 in 3 cases, and TPM2 in 1 case. Almost all (8/9) had normal first-trimester ultrasound scans except one who had an increased nuchal translucency. Seven (7/9) cases had second-trimester abnormal ultrasounds with fetal akinesia and/or extremity anomalies. Two (2/9) had only third-trimester abnormal ultrasounds with fetal akinesia and polyhydramnios, with one combined with fetal growth restriction. Four pregnancies with a positive prenatal ES were terminated, while five having not receiving prenatal ES continued to term. Only one infant survived 1 year old, and four passed away within 12 months.<BR><B>CONCLUSIONS: </B>Prenatal ultrasound can detect clues that lead to the diagnosis of NM, such as reduced or absent fetal movements, polyhydramnios and extremity anomalies.